Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool

Abstract

The AST is associated with higher pass rate than the standard MST. It seems more tolerant of high-amplitude T-waves. Consequently, the agreement between MST and AST findings was only moderate.

Editorial: Automating subcutaneous ICD screening and future sensing refinements

“…In this issue, Sakhi et al & Theuns compared 256 pts with the manual (MST) versus the AST 3 . They demonstrate no significant difference in overall eligibility between the 2 techniques reflecting the findings of two other groups who have undertaken similar studies 4,5 .…”

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks

“…Baseline assessment comprised the collection of demographic data and medical history, clinical examination, 12‐lead electrocardiogram, echocardiographic evaluation, magnetic resonance scanning, and coronary angiography (when clinically indicated). An adequate S‐ICD sensing was verified before implantation by the surface electrocardiogram (ECG) screening method that is based on a dedicated ECG morphology tool . Device surgery was undertaken under local anesthesia with ropivacaine, plus sedation with propofol (1 mg/kg bolus + infusion as to maintain spontaneous breathing).…”

“…An adequate S-ICD sensing was verified before implantation by the surface electrocardiogram (ECG) screening method that is based on a dedicated ECG morphology tool. 9 Device surgery was undertaken under local anesthesia with ropivacaine, plus sedation with propofol (1 mg/kg bolus + infusion as to maintain spontaneous breathing). Along time, we moved from a subcutaneous implant of the defibrillator can (placed posterior to the mid-axillary line) to an intermuscular placement under the latissimus dorsi that enables a more posterior location and a smaller distance from the chest wall ( Figure 1).…”

Subcutaneous defibrillators in the adult congenital heart disease population: One size does not fit all

“…Third, EKG screening for right sternal lead placement, which has been found to increase eligibility in the ACHD patients, was not included in this study . Finally, the newly developed automated screening tool that is associated with higher pass rate than the standard manual screening tool was not evaluated in the current study …”

“…9 Finally, the newly developed automated screening tool that is associated with higher pass rate than the standard manual screening tool was not evaluated in the current study. 10 Ultimately, the importance of device personalization for ACHD patients who meet criteria for defibrillator cannot be overemphasized.…”